Drawing for SYNTHEIN

USPTO serial 98248504

SYNTHEIN

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
PENDLETON, CAROLYN A
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with SYNTHEIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina Licursi

Christina Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
001Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory useACTIVE—
040Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical useACTIVE—
042Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 13, 2026EX3GSOU EXTENSION 3 GRANTED—
May 13, 2026EXT3SOU EXTENSION 3 FILED—
May 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2025EX2GSOU EXTENSION 2 GRANTED—
Nov 5, 2025EXT2SOU EXTENSION 2 FILED—
Nov 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 22, 2025EX1GSOU EXTENSION 1 GRANTED—
May 22, 2025EXT1SOU EXTENSION 1 FILED—
May 22, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 26, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 22, 2024CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Nov 18, 2024APETASSIGNED TO PETITION STAFF—
Oct 24, 2024EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 15, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 11, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2024DOCKASSIGNED TO EXAMINER—
Nov 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance